Bioavailability. The levels of test substance and relevant metabolites, as appropriate, shall be determined in whole blood, blood plasma or blood serum at appropriate intervals after initiation of intravenous, dermal, and inhalation exposure. The sampling in- tervals should be compatible with the exposure route under study. The deter- minations need only be done on ani- mals administered the test substance containing 14C-n-hexane or, if the xxx- lytical sensitivity is equal or greater, unlabeled test substance may be used.
Appears in 10 contracts
Samples: Testing Consent Agreements and Test Rules, Testing Consent Agreements and Test Rules, Testing Consent Agreements and Test Rules
